Related Experiment Videos

How many patients with dilated cardiomyopathy may potentially benefit from cardiac resynchronization therapy?

Wolfram Grimm1, Julia Sharkova, Reinhard Funck

  • 1Department of Cardiology, Hospital of the Philipps-University of Marburg, Baldingerstrasse, 35033 Marburg, Germany. Wolfram.Grimm@med.uni-marburg.de

Insights

Cardiac resynchronization therapy (CRT) candidacy varies for dilated cardiomyopathy (DCM) patients. Strict criteria identified 7% of patients, while less restrictive criteria identified 14% eligible for biventricular or left ventricular pacing.

Area of Science:

  • Cardiology
  • Medical Devices

Background:

  • Dilated cardiomyopathy (DCM) affects millions globally, often leading to heart failure.
  • Cardiac resynchronization therapy (CRT) is a treatment option for select heart failure patients.

Purpose of the Study:

  • To determine the proportion of DCM patients eligible for CRT based on varying selection criteria.
  • To analyze the impact of restrictive versus less restrictive criteria on CRT candidacy.

Main Methods:

  • Analysis of the Marburg Cardiomyopathy database (n=566).
  • Application of strict criteria: NYHA class ≥3, LVEF <30%, sinus rhythm, LBBB, QRS duration ≥150 ms.
  • Application of less restrictive criteria: NYHA class ≥3, LVEF <35%, QRS duration ≥120 ms (any BBB).

Main Results:

  • Strict criteria identified 7% (38/566) of patients as CRT candidates.
  • Less restrictive criteria identified 14% (78/566) of patients as CRT candidates.
  • Significant differences in candidacy based on criteria stringency were observed.

Conclusions:

  • CRT candidacy in DCM patients is highly dependent on the selection criteria used.
  • A substantial proportion of DCM patients may be eligible for CRT, warranting careful consideration of criteria.
  • Further research may refine optimal patient selection for CRT in DCM.

Related Concept Videos